Hjem › Type 2-diabetes › Virginia › Norfolk
Type 2-diabetes kliniske forsøg i Norfolk, VA
5 studier for Type 2-diabetes søger deltagere på steder i og omkring Norfolk (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- York Clinical Research, Norfolk
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruttererFase 3
- York Clinical Research, LLC, Norfolk
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruttererFase 3
- Research Site, Norfolk
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Norfolk
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RekruttererFase 2
- Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
Type 2-diabetes forsøg i andre byer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL24 studier
- Boston, MA20 studier
- Miami, FL19 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- Atlanta, GA17 studier
- San Diego, CA17 studier
- Los Angeles, CA16 studier
Andre studier i Norfolk
- Brystkræft16 studier
- Prostatakræft8 studier
- Blærecancer8 studier
- Ægstockræft7 studier
- Ikke-småcellet lungecancer7 studier
- Abdominal aortaaneurisme7 studier
- Hjertesvigt7 studier
- Kræft (alle typer)7 studier
- Kardiovaskulær sygdom7 studier
- Spinal muskelatrofi6 studier
- Perifer arteriesygdom5 studier
- Tripelnegativ brystkræft5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.